CPTA HOE 140
Alternative Names: Tc 99m CPTA-icatibant conjugate; Tc 99m icatibant-CPTA conjugateLatest Information Update: 16 Nov 1998
Price :
$50 *
At a glance
- Originator Aventis
- Class Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 16 Nov 1998 No Development Reported - Preclinical development for Rheumatoid arthritis (diagnosis) in Germany (IV)
- 26 Nov 1996 Preclinical development for Rheumatoid arthritis (diagnosis) in Germany (IV)